Bavarian Nordic A/S (OTCMKTS:BVNRY) Stock Crosses Below 200 Day Moving Average – What’s Next?

Bavarian Nordic A/S (OTCMKTS:BVNRY) shares crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $8.88 and traded as low as $7.48. Bavarian Nordic A/S shares last traded at $7.54, with a volume of 1,791 shares changing hands.

Bavarian Nordic A/S Trading Up 0.7 %

The business’s fifty day simple moving average is $7.72 and its 200-day simple moving average is $8.88. The firm has a market cap of $1.78 billion, a P/E ratio of 10.92 and a beta of 1.55.

Bavarian Nordic A/S (OTCMKTS:BVNRY) last posted its earnings results on Wednesday, March 5th. The company reported $0.47 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.40 by $0.07. Bavarian Nordic A/S had a return on equity of 10.65% and a net margin of 18.33%. The company had revenue of $299.48 million for the quarter, compared to analysts’ expectations of $264.06 million. Analysts anticipate that Bavarian Nordic A/S will post 0.67 earnings per share for the current year.

About Bavarian Nordic A/S

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.